Analyst Insights - Digital Health Posts

Read our Analysts’ insights and expert opinions on the latest healthcare technology industry developments and market trends. Signify Research provides both free insights and premium insights which are only available to subscribers of "Signify Premium Insights".
Click on the premium insights link below to filter for just the premium content.



Signify Premium Insight: Nines Acquisition Readies Sirona for AI Attack

Signify Premium Insights Subscription Required

10th March 2022 – As of yet, imaging IT vendors have tended to rely on partnerships rather than acquisitions to add AI capability to their portfolios. Sirona Medical has, however, bucked this trend, instead plunging into an acquisition.

Signify Premium Insight: The Fate of the Disruptors – Bruised Egos and Broken Promises?

Signify Premium Insights Subscription Required

March 8th 2022 – Several young modality vendors are looking to disrupt the medical imaging market with new technologies and innovative business models. However, as this Premium Insight explains, there are a number of challenges that must first be addressed.

Signify Premium Insight: The Fate of the Five

Signify Premium Insights Subscription Required

2nd March 2022 – The world’s largest medical imaging companies are currently competing amidst volatile conditions and disruptive technological changes. This Premium Insight assesses where these companies – GE Healthcare, Siemens Healthineers, Philips, Fujifilm and Canon – stand, and discern where they are heading.

Canon Medical Acquires Nordisk Røntgen Teknik A/S to Strengthen its High-End Fluoroscopy Portfolio

2nd March 2022 – Canon Medical this week announced an agreement to acquire NRT. The deal will see Canon strengthen its fluoroscopy and interventional portfolios, but as this Insight asks, will it help bolster its market position?

Signify Premium Insight: HeartFlow’s Deal that Failed to Rise

Signify Premium Insights Subscription Required

February 24th, 2022 – HeartFlow was set to become the medical imaging AI market’s first double unicorn when it announced in July that it was going to list publicly. Now, however, that plan has been put on hold with difficulties in agreeing a valuation, and broader external factors all playing their part.